肿瘤科指南

订阅

MedSci主页 / 所有栏目 / 肿瘤科指南

镇痛药物不良反应专家共识

2021-04-30 中国抗癌协会肿瘤营养与支持治疗专业委员会 肿瘤代谢与营养电子杂志.2021.8(2):139-143.

镇痛药物

癌症疼痛治疗（简称癌痛治疗）是癌症综合治疗的核心环节之一，其最终目标为将疼痛降低至患者能够接受的水平。但是，癌痛治疗过程中存在的不良反应在一定程度上降低了患者的生活质量。本共识旨在为癌痛患者镇痛治疗不

中文标题：

镇痛药物不良反应专家共识

发布机构：

中国抗癌协会肿瘤营养与支持治疗专业委员会

发布日期：

2021-04-30

简要介绍：

癌症疼痛治疗（简称癌痛治疗）是癌症综合治疗的核心环节之一，其最终目标为将疼痛降低至患者能够接受的水平。但是，癌痛治疗过程中存在的不良反应在一定程度上降低了患者的生活质量。本共识旨在为癌痛患者镇痛治疗不良反应的防治提供参考，以期提高癌痛患者的生活质量。

相关资料下载：
[AttachmentFileName(sort=1, fileName=镇痛药物不良反应专家共识_崔诗允.pdf)] GetToolGuiderByIdResponse(projectId=1, id=df8951c00211e882, title=镇痛药物不良反应专家共识, enTitle=, guiderFrom=肿瘤代谢与营养电子杂志.2021.8(2):139-143., authorId=0, author=, summary=癌症疼痛治疗（简称癌痛治疗）是癌症综合治疗的核心环节之一，其最终目标为将疼痛降低至患者能够接受的水平。但是，癌痛治疗过程中存在的不良反应在一定程度上降低了患者的生活质量。本共识旨在为癌痛患者镇痛治疗不, cover=https://img.medsci.cn/2021628/1624872962511_2020535.jpg, journalId=0, articlesId=null, associationId=1418, associationName=中国抗癌协会肿瘤营养与支持治疗专业委员会, associationIntro=, copyright=0, guiderPublishedTime=Fri Apr 30 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>癌症疼痛治疗（简称癌痛治疗）是癌症综合治疗的核心环节之一，其最终目标为将疼痛降低至患者能够接受的水平。但是，癌痛治疗过程中存在的不良反应在一定程度上降低了患者的生活质量。本共识旨在为癌痛患者镇痛治疗不良反应的防治提供参考，以期提高癌痛患者的生活质量。</p> </div> </div> </div>, tagList=[TagDto(tagId=103732, tagName=镇痛药物)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=29, categoryName=麻醉疼痛科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=103732, guiderKeyword=镇痛药物, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4713, appHits=249, showAppHits=0, pcHits=574, showPcHits=4462, likes=1, shares=21, comments=4, approvalStatus=1, publishedTime=Mon Jun 28 17:51:27 CST 2021, publishedTimeString=2021-04-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Mon Jun 28 17:36:16 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 14:13:26 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=镇痛药物不良反应专家共识_崔诗允.pdf)])
镇痛药物不良反应专家共识_崔诗允.pdf
下载请点击：
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1199356, encodeId=20921199356d2, content=临床实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19136534892, createdName=ms3000000282280664, createdTime=Fri Mar 04 12:02:58 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182411, encodeId=efeb118241189, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70f82992070, createdName=fanhanwen0711, createdTime=Sun Jan 09 05:07:27 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999012, encodeId=22ed9990128d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a7a2999519, createdName=hmily19870412, createdTime=Tue Jul 13 09:03:12 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977650, encodeId=64e29e765057, content=👍🏻, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=16d71991929, createdName=深院梧桐, createdTime=Mon Jun 28 18:13:18 CST 2021, time=2021-06-28, status=1, ipAttribution=)]
    2022-03-04 ms3000000282280664

    临床实用

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1199356, encodeId=20921199356d2, content=临床实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19136534892, createdName=ms3000000282280664, createdTime=Fri Mar 04 12:02:58 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182411, encodeId=efeb118241189, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70f82992070, createdName=fanhanwen0711, createdTime=Sun Jan 09 05:07:27 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999012, encodeId=22ed9990128d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a7a2999519, createdName=hmily19870412, createdTime=Tue Jul 13 09:03:12 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977650, encodeId=64e29e765057, content=👍🏻, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=16d71991929, createdName=深院梧桐, createdTime=Mon Jun 28 18:13:18 CST 2021, time=2021-06-28, status=1, ipAttribution=)]
    2022-01-09 fanhanwen0711

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1199356, encodeId=20921199356d2, content=临床实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19136534892, createdName=ms3000000282280664, createdTime=Fri Mar 04 12:02:58 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182411, encodeId=efeb118241189, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70f82992070, createdName=fanhanwen0711, createdTime=Sun Jan 09 05:07:27 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999012, encodeId=22ed9990128d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a7a2999519, createdName=hmily19870412, createdTime=Tue Jul 13 09:03:12 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977650, encodeId=64e29e765057, content=👍🏻, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=16d71991929, createdName=深院梧桐, createdTime=Mon Jun 28 18:13:18 CST 2021, time=2021-06-28, status=1, ipAttribution=)]
    2021-07-13 hmily19870412

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1199356, encodeId=20921199356d2, content=临床实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19136534892, createdName=ms3000000282280664, createdTime=Fri Mar 04 12:02:58 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182411, encodeId=efeb118241189, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70f82992070, createdName=fanhanwen0711, createdTime=Sun Jan 09 05:07:27 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999012, encodeId=22ed9990128d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a7a2999519, createdName=hmily19870412, createdTime=Tue Jul 13 09:03:12 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977650, encodeId=64e29e765057, content=👍🏻, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=16d71991929, createdName=深院梧桐, createdTime=Mon Jun 28 18:13:18 CST 2021, time=2021-06-28, status=1, ipAttribution=)]
    2021-06-28 深院梧桐

    👍🏻

    0